The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis
- 6 December 2016
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (3) , 353-357
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Autoimmune encephalitis: paving the way for early diagnosisThe Lancet Neurology, 2016
- Quantification of the novelN-methyl-d-aspartate receptor ligand [11C]GMOM in manJournal of Cerebral Blood Flow & Metabolism, 2015
- Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) ProjectJournal of Alzheimer’s Disease, 2015
- Guidance for reading FDG PET scans in dementia patients.2014
- Anti-leucine rich glioma inactivated 1 protein and anti-N-methyl-D-aspartate receptor encephalitis show distinct patterns of brain glucose metabolism in 18F-fluoro-2-deoxy-d-glucose positron emission tomographyBMC Neurology, 2014
- Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingNeuroImage: Clinical, 2014
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort studyThe Lancet Neurology, 2013
- EANM/SNMMI Guideline for18F-FDG Use in Inflammation and InfectionJournal of Nuclear Medicine, 2013
- N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexesBrain, 2010
- Mild cognitive impairmentNeurology, 2003